• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从真实世界数据到真实世界证据,改善神经眼科的结局。

From real world data to real world evidence to improve outcomes in neuro-ophthalmology.

机构信息

Department of Neuroscience, Central Clinical School, Faculty of Medicine, Nursing and Health Science, Monash University, Melbourne, VIC, Australia.

Department of Neurology, Alfred Hospital, Melbourne, VIC, Australia.

出版信息

Eye (Lond). 2024 Aug;38(12):2448-2456. doi: 10.1038/s41433-024-03160-8. Epub 2024 Jun 6.

DOI:10.1038/s41433-024-03160-8
PMID:38844583
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11306594/
Abstract

Real-world data (RWD) can be defined as all data generated during routine clinical care. This includes electronic health records, disease-specific registries, imaging databanks, and data linkage to administrative databases. In the field of neuro-ophthalmology, the intersection of RWD and clinical practice offers unprecedented opportunities to understand and treat rare diseases. However, translating RWD into real-world evidence (RWE) poses several challenges, including data quality, legal and ethical considerations, and sustainability of data sources. This review explores existing RWD sources in neuro-ophthalmology, such as patient registries and electronic health records, and discusses the challenges of data collection and standardisation. We focus on research questions that need to be answered in neuro-ophthalmology and provide an update on RWE generated from various RWD sources. We review and propose solutions to some of the key barriers that can limit translation of a collection of data into impactful clinical evidence. Careful data selection, management, analysis, and interpretation are critical to generate meaningful conclusions.

摘要

真实世界数据(RWD)可定义为在常规临床护理过程中生成的所有数据。这包括电子健康记录、特定疾病的登记处、成像数据库以及与行政数据库的数据链接。在神经眼科学领域,RWD 与临床实践的交叉为理解和治疗罕见疾病提供了前所未有的机会。然而,将 RWD 转化为真实世界证据(RWE)面临着一些挑战,包括数据质量、法律和伦理考虑以及数据源的可持续性。本综述探讨了神经眼科学中现有的 RWD 来源,如患者登记处和电子健康记录,并讨论了数据收集和标准化的挑战。我们重点关注神经眼科学中需要回答的研究问题,并提供了来自各种 RWD 来源生成的 RWE 的最新信息。我们审查并提出了解决一些可能限制将数据集合转化为有影响力的临床证据的关键障碍的方法。仔细的数据选择、管理、分析和解释对于得出有意义的结论至关重要。

相似文献

1
From real world data to real world evidence to improve outcomes in neuro-ophthalmology.从真实世界数据到真实世界证据,改善神经眼科的结局。
Eye (Lond). 2024 Aug;38(12):2448-2456. doi: 10.1038/s41433-024-03160-8. Epub 2024 Jun 6.
2
Real-World Evidence: A Primer.真实世界证据:基础篇。
Pharmaceut Med. 2023 Jan;37(1):25-36. doi: 10.1007/s40290-022-00456-6. Epub 2023 Jan 5.
3
Real-world evidence and product development: Opportunities, challenges and risk mitigation.真实世界证据与产品开发:机遇、挑战与风险缓解。
Wien Klin Wochenschr. 2021 Aug;133(15-16):840-846. doi: 10.1007/s00508-021-01851-w. Epub 2021 Apr 9.
4
Data Science Methods for Real-World Evidence Generation in Real-World Data.用于真实世界数据中生成真实世界证据的数据科学方法。
Annu Rev Biomed Data Sci. 2024 Aug;7(1):201-224. doi: 10.1146/annurev-biodatasci-102423-113220. Epub 2024 Jul 24.
5
Contemporary Databases in Real-world Studies Regarding the Diverse Health Care Systems of India, Thailand, and Taiwan: Protocol for a Scoping Review.关于印度、泰国和台湾地区多样化医疗保健系统的真实世界研究中的当代数据库:一项范围综述方案
JMIR Res Protoc. 2022 Dec 13;11(12):e43741. doi: 10.2196/43741.
6
Contemporary use of real-world data for clinical trial conduct in the United States: a scoping review.美国临床试验中使用真实世界数据的当代应用:范围综述。
J Am Med Inform Assoc. 2021 Jan 15;28(1):144-154. doi: 10.1093/jamia/ocaa224.
7
Real-world data: a comprehensive literature review on the barriers, challenges, and opportunities associated with their inclusion in the health technology assessment process.真实世界数据:纳入卫生技术评估过程中相关障碍、挑战和机遇的全面文献综述。
J Pharm Pharm Sci. 2024 Feb 28;27:12302. doi: 10.3389/jpps.2024.12302. eCollection 2024.
8
Expert survey on real-world data utilization and real-world evidence generation for regulatory decision-making in drug lifecycle in Korea.韩国药物生命周期监管决策中真实世界数据利用和真实世界证据生成的专家调查。
Clin Transl Sci. 2024 Apr;17(4):e13801. doi: 10.1111/cts.13801.
9
Use of Clinical Data Interchange Standards Consortium (CDISC) Standards for Real-world Data: Expert Perspectives From a Qualitative Delphi Survey.临床数据交换标准协会(CDISC)标准在真实世界数据中的应用:来自定性德尔菲调查的专家观点
JMIR Med Inform. 2022 Jan 27;10(1):e30363. doi: 10.2196/30363.
10
The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid Leukemia.真实世界证据在慢性髓性白血病临床研究未来中的应用。
Clin Ther. 2019 Feb;41(2):336-349. doi: 10.1016/j.clinthera.2018.12.013. Epub 2019 Jan 30.

引用本文的文献

1
Neuro-ophthalmology: recent advances and paradigm shifts.神经眼科学:最新进展与范式转变
Eye (Lond). 2024 Aug;38(12):2233-2234. doi: 10.1038/s41433-024-03188-w. Epub 2024 Jun 26.

本文引用的文献

1
Prediction Models for Glaucoma in a Multicenter Electronic Health Records Consortium: The Sight Outcomes Research Collaborative.多中心电子健康记录联盟中青光眼的预测模型:视力结果研究协作组
Ophthalmol Sci. 2023 Dec 6;4(3):100445. doi: 10.1016/j.xops.2023.100445. eCollection 2024 May-Jun.
2
Introducing a core dataset for real-world data in multiple sclerosis registries and cohorts: Recommendations from a global task force.引入用于多发性硬化症登记处和队列研究的真实世界数据核心数据集:全球特别工作组的建议。
Mult Scler. 2024 Mar;30(3):396-418. doi: 10.1177/13524585231216004. Epub 2023 Dec 23.
3
Teleophthalmology and retina: a review of current tools, pathways and services.远程眼科与视网膜:当前工具、途径及服务综述
Int J Retina Vitreous. 2023 Dec 5;9(1):76. doi: 10.1186/s40942-023-00502-8.
4
The impact of month and season on the incidence of giant cell arteritis: an Intelligent Research in Sight (IRIS) Registry analysis.月份和季节对巨细胞动脉炎发病的影响:智能研究视野(IRIS)登记分析。
Graefes Arch Clin Exp Ophthalmol. 2024 Feb;262(2):609-614. doi: 10.1007/s00417-023-06268-x. Epub 2023 Oct 11.
5
Deep neural network-estimated age using optical coherence tomography predicts mortality.基于光学相干断层扫描的深度神经网络估计年龄可预测死亡率。
Geroscience. 2024 Apr;46(2):1703-1711. doi: 10.1007/s11357-023-00920-4. Epub 2023 Sep 21.
6
The Vienna idiopathic intracranial hypertension database-An Austrian registry.维也纳特发性颅内高压数据库-奥地利登记处。
Wien Klin Wochenschr. 2024 Jan;136(1-2):32-39. doi: 10.1007/s00508-023-02252-x. Epub 2023 Aug 31.
7
Developing a Quality Assurance Framework for Neuro-Ophthalmology Using a Multisite Data Registry.运用多中心数据注册系统开发神经眼科学质量保证框架。
J Neuroophthalmol. 2024 Jun 1;44(2):267-272. doi: 10.1097/WNO.0000000000001943. Epub 2023 Jul 20.
8
Asymptomatic idiopathic intracranial hypertension: Prevalence and prognosis.无症状特发性颅内高压:患病率和预后。
Clin Exp Ophthalmol. 2023 Aug;51(6):598-606. doi: 10.1111/ceo.14256. Epub 2023 May 27.
9
Longitudinal prospective cohort study evaluating prognosis in idiopathic intracranial hypertension patients with and without comorbid polycystic ovarian syndrome.评价有无合并多囊卵巢综合征的特发性颅内高压患者预后的前瞻性队列研究。
Eye (Lond). 2023 Dec;37(17):3621-3628. doi: 10.1038/s41433-023-02569-x. Epub 2023 May 24.
10
Thyroid Eye Disease and its Vision-Threatening Manifestations in the Academy IRIS Registry: 2014-2018.甲状腺眼病及其在 Academy IRIS 注册研究中的威胁视力表现:2014-2018 年。
Am J Ophthalmol. 2023 Sep;253:74-85. doi: 10.1016/j.ajo.2023.04.013. Epub 2023 May 17.